1:26 PM
 | 
Dec 04, 2018
 |  BC Extra  |  Politics & Policy

Biosimilar makers back Pfizer in call to end misleading brand marketing

A group of biosimilar manufacturers including Pfizer Inc. (NYSE:PFE) urged FDA to produce supplemental guidance clarifying how to comply with existing law when communicating about biosimilars. The Biosimilars Forum sent its plea in a letter supporting an August Citizen's Petition from Pfizer asking FDA to take action against branded drugmakers that the pharma said have misled the public about the safety or efficacy of biosimilars.

The group also asked FDA to direct companies that have run misleading campaigns...

Read the full 375 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >